Modified Fisher Scale Calculator – Subarachnoid Hemorrhage Vasospasm Risk
CT Hemorrhage Assessment
Select the subarachnoid blood thickness and whether intraventricular hemorrhage is present on the admission CT.
This is a radiographic risk-stratification grade, not an individual probability of vasospasm or delayed cerebral ischemia. It does not replace neurological examination, clinical monitoring, vascular imaging, or specialist assessment.
About the Modified Fisher Scale
The Modified Fisher Scale is a CT-based grading system for subarachnoid hemorrhage that incorporates both the thickness of cisternal blood and the presence of intraventricular hemorrhage. It was developed to improve prediction of symptomatic vasospasm compared with the original Fisher scale.
Use the admission non-contrast head CT and assess the cisternal/fissural blood burden together with ventricular blood. The scale is most appropriately applied in the context of aneurysmal SAH; the CT pattern should be interpreted by a qualified clinician.
Grade definitions
| Grade | Cisternal SAH | IVH |
|---|---|---|
| 0 | No visible SAH | Absent |
| 1 | Thin (<1 mm) | Absent |
| 2 | Thin (<1 mm) | Present |
| 3 | Thick (≥1 mm) | Absent |
| 4 | Thick (≥1 mm) | Present |
Clinical use and limitations
- Higher grades are associated with greater risk of symptomatic vasospasm at a population level.
- The grade is not a stand-alone prediction of an individual patient's outcome and does not quantify a calibrated absolute risk.
- It does not directly diagnose vasospasm or delayed cerebral ischemia.
- Clinical severity, neurological status, aneurysm characteristics, treatment, and other patient factors also influence outcome.
- Isolated IVH without visible cisternal SAH is not represented in the five canonical combinations above; do not force a grade.
Evidence & References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.